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Abstract  
 
Multiple clinical and experimental evidence suggest that ALS and FTLD are 
members of a disease continuum. Pathological FUS inclusions have been 
observed in subsets of patients with these diseases but their anatomical 
distribution is different for two diseases. These structures are present in motor 
neurons in ALS cases but in cortical neurons in FTLD cases. Expression of a C-
terminally truncated form of human FUS causes an early onset and progressive 
motor neuron pathology in transgenic mice but only when these neurons express 
a certain level of this protein. Severe motor dysfunction and early lethality of 
mice with expression above this level prevent their use for studies of FTLD-
related pathology caused by expression of this form of FUS. In the present 
study we used another line of mice expressing the same protein but not 
developing any signs of motor system dysfunction due to substantially lower 
level of transgene expression in motor neurons. In a set of tests 5-month old 
mice displayed certain behavioural abnormalities, including increased 
impulsivity, decreased anxiety and compromised social interaction, that 
recapitulate behaviour characteristics typically seen in FTLD patients.   
 
 
Introduction 
 
Frontotemporal lobar degeneration (FTLD) is a key histopathological feature of 
frontotemporal dementia (FTD), the second common type of dementia  in the 
presenile age group making up 5 – 15% of cases (reviewed in Ref. 1). Clinical 
symptoms include progressive deterioration of patients’ behaviour, distortion 
(defacing) the personality, and problems with cognitive domains such as 
language, speech and memory. The pace of the disease progression varies as 
well as prevalence and severity of clinical symptoms particularly at the early 
stages of the disease when predominantly behavioural or predominantly 
linguistic changes are common 2. 
A hallmark of FTLD is the presence of intraneuronal inclusion bodies that vary 
in morphology and protein composition. Based on post-mortem analysis the 
majority of cases can be classified as those with TDP43-positive or those with 
tau-positive pathological inclusions however, the less common third type exists 
with FET protein deposits in frontal and temporal lobes of brain 1. 
 
FET proteins comprise a family of highly conserved predominantly nuclear 
proteins that include FUS, EWS and TAF15. These proteins are ubiquitously 
expressed and involved in regulation of gene expression, as well as in RNA 
processing, transport and metabolism 3, 4.  
The role of FUS in FTLD pathology is well established, although mutations in 
FUS are usually associated with ALS and extremely rarely found in FTLD 
patients with only three familial cases have been reported (two FTLD/ALS and 
one pure FTLD) 5, 6, 7. So far there is no clear understanding why FUS gene 
mutations virtually inevitably cause ALS rather than FTLD and what defines 
anatomical localisation of FUS pathology that is restricted to frontal and 
temporal lobes in idiopathic FTLD.  
 
In healthy neurons FUS is mainly localised in the nucleus but also shuttles to 
the cytoplasm; in both cell compartments it is involved in various steps of RNA 
processing and transport. Most common disease-associated mutations of the 
FUS gene affect the C-terminal nuclear localisation signal of the encoded 
protein causing its accumulation in the cytoplasm and at least partial depletion 
of its nuclear pool. It is believed that the amount of FUS accumulated in the 
cytoplasm should reach a critical level to trigger pathological changes that 
eventually cause dysfunction and death of the affected neuron, and this level 
might be different for different types of neurons.  
 
Expression of ALS/FTLD-associated genes in transgenic rodents at a relatively 
high level produces phenotype resembling ALS, while animals with low levels 
of transgene expression stay healthy. This makes it difficult to produce rodent 
models of FTLD based on expression of the disease associated genes and 
proteins. Nevertheless, in some models, ageing animals display behavioural 
changes recapitulating certain symptoms observed in FTLD patients. For 
example, aged rats with overexpression of wild type human FUS have 
developed deficit in spatial learning and memory as a result of neuronal loss in 
the cortex and dentate gyrus 8.  
 
Previously we have produced a transgenic mouse line, S-FUS[1-359], 
expressing high level of a C-terminally truncated human FUS protein (FUS 1-
359), which caused FUSopathy with sudden offset of severe motor phenotype 
and early lethality 9. Analysis of another line, L-FUS[1-359], revealed a similar 
number of tandemly arranged copies of the same transgenic cassette located at 
Chr 11 but the level of human FUS expression in the nervous system of these 
mice was substantially lower than in the first line with different genomic 
location of the cassette at Chr 12. The low level of expression in the spinal cord 
was not sufficient to trigger the development of motor phenotype in L-FUS[1-
359] mice, although RNA sequencing identified a set of genes that change their 
expression in the spinal cord of these mice 10. 
 
Here we demonstrate that L-FUS[1-359] mice develop behavioural 
impairments. At the age of 5 months these animals display increased 
impulsivity, decreased anxiety and compromised social interaction behaviour.  
 
 
Materials and Methods 
Animals and ethics approval 
A transgenic mouse line, L-FUS[1-359] with neurospecific expression of a C-
terminally truncated human FUS has been produced as described previously 9 
and transferred to CD1 genetic background 10 in a specific pathogen free facility 
of IPAC RAS. Experimental animals were single cage housed and maintained at 
constant temperature (22°C) on a 12 h light/dark cycle with ad libitum access to 
food and water.  
 
All animal experiments were approved by The Bioethics committee of Institute 
of Physiologically Active Compounds, Russian Academy of Sciences 
(Approval No. 20 dated 23.06.2017).  
 
Genotyping  
Transgenic cassette has been detected in genomic DNA from ear biopsies by 
qPCR as described previously 9, 10.  
 
Quantitative RT-PCR  
Total RNA was extracted from mouse brain cortex, cerebellum and spinal cord 
using RNeasy Plus Mini Kit with genomic DNA eliminator columns (Qiagen) 
and 1 µg of total RNA was used for synthesis of the first-strand cDNA  in 
reverse transcription reaction with random hexamer primers according to 
manufacturer’s instructions (Evrogen, Russia). The first-strand cDNA was used 
as a template in real-time qPCR amplification reaction using qPCR HS SYBR 
mix (Evrogen, Russia) and the CFX96 real-time PCR detection system 
(Biorad). For detection of human FUS transcript encoded by the transgenic 
cassette primers 5’-TCTTTGTGCAAGGCCTGGGT-3’ and 5’-
TAATCATGGGCTGTCCCGTT-3’ were used. GAPDH was used as a 
reference gene (primers 5’-CACTGAGCATCTCCCTCACA-3’ and 5’-
GTGGGTGCAGCGAACTTTAT-3’). The cycle parameters were as follows: 10 
min at 95°C followed by 40 cycles of 15 s at 95°C and 60 s at 60°C.  
 
Protein extraction and Western blot analysis  
Total protein samples were prepared by homogenisation of dissected mouse 
tissues in 2xSDS-PAGE loading buffer followed by incubation at 100oC for 5 
min. Separation of  proteins in SDS-PAGE and consequent semidry transfer on 
PVDF membrane (GE Healthcare) were performed as described elsewhere 10, 11. 
Human FUS protein was detected using rabbit polyclonal antibody 14080 (a 
kind gift from Don Cleveland) specific to the N-terminal epitope of human FUS 
protein, secondary anti-rabbit HRP-conjugated antibodies (GE Healthcare) and 
WesternBright TM Sirius chemiluminescent detection system (Advansta). The 
membranes were re-probed with mouse monoclonal antibody against beta-actin 
(clone AC-15, Sigma-Aldrich) for loading control.  
 
Immunohistochemistry 
Paraffin-embedded parasagittal sections of paraformaldehyde-fixed mouse 
brains were immunostained with human FUS specific rabbit polyclonal 
antibody 14080 as described elsewhere 12, 13. 
 
Behavioural tests 
Transgenic male L-FUS[1-359] mice (N=12) and their wild type male 
littermates (N=12) were moved to the testing room one hour prior commencing 
testing. All behavior tests were performed during the light cycle, between 10:00 
a.m. and 3:00 p.m. Tests were performed in the following order: water induced 
grooming, light-dark box, elevated O-maze, fear conditioning test, resident-
intruder test with the 5 days intervals between them. 
Dark-light box camera consisted of two compartments: light zone (30 × 20 × 
25 cm, 100 lux) and dark zone (15 × 20 × 25 cm). Mice were placed into the 
dark compartment and their movements were recorded for 5 minutes using 
Logitech HD 720p camera. The video records were analysed for the latency 
time for the first exit to the light compartment, total number of exits and total 
duration of time spent in the light compartment 14.  
Elevated O-maze consisted of a black circular path (runway width 5.5 cm, 
diameter 46 cm) that was placed 40 cm above the floor. Two opposing 
compartments were upbuild by walls of 10 cm in height. A testing mouse was 
placed in the middle of closed compartment and recorded for 5 minutes using 
Logitech HD 720p camera. The video records were analysed for latency time of 
the first exit to the anxietygenic open compartments, the number of exits from 
the closed compartments and total duration of time spent in open (light) 
compartments. Illumination intensity was kept at 50 Lux 14, 15. 
Water induced grooming. Spontaneous grooming was induced by misting the 
mouse with the room temperature water (250C) using standard spray bottle in 
‘misting’ mode. The mouse was gently fixed by the tail and sprayed three times 
toward the mice head from the 10 cm distance, placed into the observation glass 
cylinder and its grooming behavior was recorded for 10 minutes.  The total time 
spent grooming and number of grooming episodes (bouts) were registered 16. 
Fear conditioning test.  On the first training day a mouse was placed on the 
metal grid floor in the conditioning apparatus chamber and after 118 sec delay a 
2-sec electric foot shock (1.5 mA) was applied. The animal was returned to the 
home cage immediately thereafter. 24 hours after the training, this mouse was 
re-exposed to the same apparatus chamber and the percentage of time spent 
freezing was measured for 180 sec, followed by 7 minutes of re-exploring the 
box under shock-free conditions for memory extinction. 24 hours later, i.e. on 
the third experimental day, the mouse was exposed to the chamber again and the 
percentage of time spent freezing was re-measured for 180 sec 17. 
Resident-intruder test. Each resident mouse was housed individually, bedding 
material in resident’s cages hasn’t been changed for a week before testing. 
Thereafter, a male mouse of the same strain and a similar weight and age to that 
of the resident, and housed in the group before the test was introduced as an 
intruder. The number of social contacts and acts of aggression were recorded for 
8 min. 
 
Statistical analysis was performed using GraphPad 7.0 software (San Diego, 
USA). For comparing relative mRNA levels Kruskal-Wallis ANOVA and 
Dunn’s multiple comparisons test were used. Nonparametric Mann-Whitney U-
test was used when data for two groups were compared. The level of statistical 
significance was set at p< 0.05. Results are presented as mean ± SEM.  
 
Results 
Expression of human FUS in the nervous system of L-FUS[1-359] mice. 
The levels of human FUS mRNA expressed under control of Thy-1 regulatory 
elements were compared by real-time quantitative RT-PCR. Total RNA samples 
were prepared from the cortex, cerebellum and spinal cord of five L-FUS[1-
359] aging homozygous males (average age 299 days) and individually reverse 
transcribed followed by the real-time qRT-PCR with primers specific for human 
FUS mRNA. The level of expression was lowest in the cerebellum, and in the 
cortex and spinal cord it was 6.5 and 4.7 times higher, respectively (Fig 1a). 
 
A semi-quantitative Western blot analysis demonstrated that the truncated 
human FUS protein is more abundant in total protein samples extracted from 
the cortex of 2-month old heterozygous L-FUS[1-359] than 2-month old 
heterozygous S-FUS[1-359] mice (Fig 1b).  
 
Immunohistochemistry with antibody specific to human FUS protein revealed 
the highest level of human FUS protein in the cytoplasm of large neurons 
predominantly localised in the layer V of the cerebral cortex of L-FUS[1-359] 
mice. The protein was evenly distributed in the cytoplasm of these neurons and 
did not form inclusions (Fig 1c). Consistently with the result of Western blot 
analysis, substantially weaker signals were detected in cortical neurons of S-
FUS[1-359] mice, although these weakly positive neurons were more spread 
across the cortex layers of these mice (Fig 1c).   
 
Behavioral analysis of L-FUS[1-359] mice 
Cognitive function was analysed in 5 months old L-FUS[1-359] male mice 
homozygous for the transgenic cassette compared to their wild type male 
littermates. 
 
The dark-light box was employed to study the anxiety. The normal behaviour of 
wild type mice is characterised by preference of dark compartment of the 
apparatus towards the open illuminated one. Therefore, the number of exits 
from the dark compartment to the open illuminated zone and total time that the 
animals have spent in this zone could reflect the level of their anxiety. L-FUS[1-
359] mice entered the open illuminated compartment of the camera more often 
than control wild type mice (Fig 2a). The number of light compartment entries 
for L-FUS[1-359] mice was statistically significantly higher (U=32, p<0.05) 
than for the control group. The latency time to the first exit from the dark 
compartment to the open compartment was also shorter in the L-FUS[1-359] 
group than in the control group (U=21, p<0.01). Although the total time spent in 
the illuminated open compartment by in L-FUS[1-359] mice had a tendency to 
increase, this difference was not statistically significant (p=0.08). These data 
clearly demonstrate that L-FUS[1-359] mice exhibit a lower level of anxiety 
and higher level of impulsivity than their wild type littermates. 
 
Decreased anxiety of L-FUS[1-359] mice was even more obvious in the 
elevated O-maze test (Fig 2b). L-FUS[1-359] mice spent significantly longer 
time in the open arm compared to the wild type control animals (U=7, 
p<0.0001). The number of entries to the open sector of the maze was also much 
higher (U=5, p<0.0001). Moreover, the latency time that L-FUS[1-359] mice 
took for the first exit to the open arm of the maze was shorter than for wild type 
controls (U=22, p<0.01).  
 
To study the repetitive behavior that is known to be affected in FTD patients 
and that may reflect the pathology in the model animals with amygdala and 
striatal dysfunction, we have analysed the spontaneous grooming in L-FUS[1-
359] mice. Misting a mouse with the room temperature water induces 
spontaneous self-grooming that consists of specific and highly stereotyped 
patterns of four sequential movements (bouts). Stress and anxiety in animals is 
often accompanied by increased self-grooming and disorganized patterning 16.  
 
Neither the number of grooming episodes (full bouts) (p=0.6), no total 
grooming time (p=0.4) were different in L-FUS[1-359] mice when compared to 
wild type controls (Fig 3). 
 
A long-term memory formation has been tested in L-FUS[1-359] mice using the 
fear conditioning test (Fig 4a). A significant decrease in time spent freezing was 
found in L-FUS[1-359] mice versus the control group during a recall of fear 
conditioning 24 h post-training (U=33.5, p<0.05). 48 hours after the initial 
training, during the recall of memory extinction, the L-FUS[1-359] mice did not 
exhibit the decrease of freezing behaviour from the level detected during the 
recall of fear conditioning 24 h post-training (p=0.17), which was obvious for 
wild type animals (U=36, p< 0.05).  
 
Social behaviour of resident males were analysed by the number of contacts and 
number of attacks towards intruder (Fig. 4b). Transgenic L-FUS[1-359] mice 
shows less social interest (U=16,  p<0.001) compared to wild type mice. There 
is no statistical difference in aggression behaviour with neither transgenic L-
FUS[1-359] nor wild type mice have shown high level of aggression. However, 
L-FUS[1-359] mice spent significantly less time (U=25, p<0.01) exploring 
intruder mice (Fig. 4c), which can indicate social stress in animals that 
recapitulates a clinical symptom of FTD. 
  
Discussion 
Malfunction of DNA/RNA-binding protein FUS causes certain forms of 
amyotrophic lateral sclerosis (FUS-ALS) and frontotemporal lobar degeneration 
(FUS-FTLD) (reviewed in Ref. 18). Mislocalisation of normally nuclear FUS to 
the cytoplasm is believed to be a key trigger or first-hit in the pathological 
cascade that leads to dysfunction and eventual death of neurons 19, 20. The 
severity of the neurodegenerative changes directly correlates with the degree of 
FUS mislocalisation in patients’ neurons 21, 22, 23. Therefore, expression of C-
terminally truncated FUS, which translocation to the nucleus is substantially 
compromised due to complete lack of its nuclear localisation signal, appeared to 
be a suitable approach to recapitulate pathological traits of human diseases in 
genetically altered mice. Pathological changes are developed in the nervous 
systems even when truncated FUS is expressed from the edited endogenous Fus 
locus in knockin mice 24, 25, 26. Similarly, in the spinal cord of S-FUS[1-359] 
transgenic mice expression of C-terminally truncated human FUS under control 
of Thy-1 regulatory sequences at the level lower than the level of endogenous 
mouse FUS causes severe early onset motor neuron pathology 9. However, mice 
of L-FUS[1-359] transgenic line with further reduced expression level of the 
same truncated variant of FUS in the spinal cord do not develop motor neuron 
pathology and have normal lifespan 9, 10. This is consistent with results of 
studies of other FUS transgenic mice that demonstrated a direct correlation 
between the level of transgene expression and the severity of pathological 
changes 27. It is feasible that the low level of mislocalised pathogenic form of 
FUS protein can be successfully compensated by certain intrinsic defence 
mechanisms of motor neurons. 
 
In contrast to much lower level of the truncated FUS expression in the spinal 
cord of L-FUS[1-359] mice as compared to S-FUS[1-359] mice 10, its 
expression in the cerebral cortex of L-FUS[1-359] transgenic mice is higher 
than in the cerebral cortex of S-FUS[1-359] mice. This difference is most 
probably due to effects of endogenous mouse regulatory elements in the vicinity 
of transgene integration sites in these two mouse lines. However, this level of 
expression and mislocalisation of truncated FUS lacking nuclear localisation 
signal are not sufficient to trigger pathological aggregation in the cytoplasm of 
cortical neurons. Nevertheless, it is feasible that even in the absence of FUS 
inclusions, persistent expression of a pathogenic FUS variant in the cerebral 
cortex neurons might cause their dysfunction and the development of clinical 
signs relevant to some symptoms of FTLD. Importantly, the absence of motor 
deficiency in L-FUS[1-359] mice allowed us to test this hypothesis using 
behavioural paradigms that require uncompromised movement ability of 
experimental animals.  
 
Results of these experiments have indeed revealed changes in the behaviour and 
cognition of young adult homozygous transgenic L-FUS[1-359] male mice.  
Decreased anxiety of L-FUS[1-359] when compared to their wild type control 
littermates has been demonstrated in two tests that are commonly used for the 
assessment of the anxiety and risk-taking behaviour, namely the dark-light box 
and elevated O-maze. In both tests, transgenic mice entered earlier and showed 
increased number of entries into the brighter illuminated compartments. In the 
elevated O-maze transgenic mice also spent more time exploring the open arm. 
Short latency time to exit from the dark compartment is a parameter that 
reflecting impulsivity and the increased exploratory interest in the light 
compartments is an indicator of decreased anxiety, which  could be interpreted 
as excessive risk-taking behaviour and/or disinhibition or even emotional 
dysfunction, which are often observed in FTLD patients 28. 
  
The development of a memory deficit is not uncommon in FTLD patients and 
therefore we studied formation of memory in L-FUS[1-359] mice using the 
extinction fear conditioning test. In mice, freezing in response to an adverse 
stimulus, like an electric shock used in this test, reflects their formation of 
memory to the context. 24 hours after receiving an electric shock, transgenic L-
FUS[1-359] mice showed significantly shorter time remaining motionless than 
wild type control animals. As this time was already similar to time that wild 
type spent motionless during assessment of the recall of memory extinction, it 
was not expected to see further reduction of the freezing time for L-FUS[1-359] 
mice during this assessment and indeed this has not been observed. The 
decreased level of freezing behaviour in response to a fear-conditioned stimulus 
can be interpreted as an impairment of long-term memory formation in 
transgenic L-FUS[1-359] mice 17, however it could not be excluded that the 
decreased anxiety demonstrated in other tests affects animal behaviour in this 
test as well. 
 
Changes in social behaviour is one of the main symptoms of FTLD and L-
FUS[1-359] mice recapitulated these changes in the resident-intruder test. 
Transgenic mice had a decreased number of social interactions, were much less 
interested in any type of physical contact with intruder mice and showed no 
signs of aggressive behaviour.  
 
Repetitive behavior is a common symptom in FTLD patients and may be 
represented in mice by abnormal repetitive grooming 29. However, the induced 
self-grooming in L-FUS[1-359] mice was nоt significantly different from the 
wild type control animals. 
 
Certain mouse lines that display altered social engagement, reduced anxiety, 
hyperactivity and memory impairments are regarded as models of 
frontotemporal dementia. These include GRN knockout mice and transgenic 
mice expressing mutant tau, TDP-43 lacking the nuclear localisation signal and 
FUS with a C-terminal shorter than in our mice  30, 31, 32, 33. Overall, behavioural 
abnormalities observed in L-FUS[1-359] mice are consistent with those 
reported for these mouse models. 
 
In conclusion, results of our study suggest that expression of a pathogenic form 
of human FUS in mouse cortical neurons at a low level that does not trigger 
formation of FUS inclusions and in the absence of motor deficiency causes 
decreased anxiety, increased impulsivity and changes in social interaction, 
which are indicators of FTLD-like pathology. 
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Figure Legends 
Figure 1. Expression of C-terminally truncated form of human FUS in the 
nervous system of L-FUS[1-359] mice.  
(a) Relative levels of expression of transgenically expressed human FUS 
mRNA in the brain regions of aging L-FUS[1-359] mice assessed by real-time 
qRT-PCR with primers specific for human FUS mRNA. Total RNA samples 
from five ageing (average age 299 days) homozygous L-FUS[1-359] male mice 
were analysed in triplicates (Kruskal-Wallis ANOVA with Dunn’s multiple 
comparisons test, **p<0.01, *p<0.05). 
  
(b) Western blot analysis of total protein samples extracted from the cortex of 2-
month old hemizygous L-FUS[1-359], S-FUS[1-359] and wild type (WT) mice 
with antibody specific to human FUS. For loading control the same membrane 
was re-probed with anti-beta-actin antibody. 
 
(c) Immunostaining of histological sections through the frontal cortex of L-
FUS[1-359], S-FUS[1-359] and wild type (WT) mice with antibody specific to 
human FUS. Scale bar, 100 µm. 
  
Figure 2. Behaviour tests for anxiety.  
(a) In the light dark box test, transgenic L-FUS[1-359] mice display only a 
tendency to spent longer time in the light compartment (U=42, p=0.08) as 
compared to control WT mice. However, there was a significant reduction in the 
latency to first exit to the light compartment in L-FUS[1-359] mouse group 
(U=21, p<0.01). L-FUS[1-359] animals also have a significantly increased 
number of exits to the light compartment compared to control animals (U=32, 
p<0.05).  
(b) In the elevated O-maze test L-FUS[1-359] mice displayed dramatically 
increased time spent in the open arm (U=7, p<0.0001) and the number of entries 
to the open arm (U=5, p<0.0001), as well as decreased latency to first exit to the 
open arm (U=22, p<0.01) compared to control WT animals. N=12 for both 
groups.  
 
Figure 3. Water induced grooming test.  
Analysis of induced self-grooming in mice shows no significant changes in 
grooming behaviour between L-FUS[1-359] and wild type animals in the 
grooming time (U=57, p=0.4) and in the number of grooming bouts (U=63, 
p=0.6).  
N=12 for both groups. 
 
Figure 4. Analysis of memory and social function.  
(a) In the contextual post-training fear-conditioning test, L-FUS[1-359] animals 
spent significantly lower time freezing than control animals (U=33.5, p < 0.05).  
No significant differences  between groups in the duration of freezing behaviour 
were observed in the test for extinguishing of contextual fear conditioning 
(p=0.09). Wild type mice demonstrate significant decrease in the time spent 
freezing 48 hours after the initial training compared to 24 h post-training 
because, suggesting that mice have retrained in the post-training session (U=36, 
p< 0.05).  
(b) Analysis of social behaviour in resident-intruder test show that L-FUS[1-
359] mice demonstrate significantly less social interest (U=16, p<0.001) in 
exploring the intruder mice. Both L-FUS[1-359] and wild type mice has not 
shown high level of aggression and violence. 
(c) Analysis of the duration of social contacts in resident-intruder test also 
demonstrate that L-FUS[1-359] mice spent significantly less time (U=25, 
p<0.01) exploring intruder mice. 
N=12 for both groups. 
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